1Division of Medical Oncology, Department of Uro-Gynaecological Oncology, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale,”, Naples, Italy
2Department of Onco-Ematology Medical Oncology, S.G. Moscati Hospital of Taranto, Taranto, Italy
3Unit of Epidemiology, Struttura Complessa di Statistica Medica, Biometria e Bioinformatica, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale,”, Naples, Italy
4Pharmacy Unit, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale,”, Naples, Italy
5Division of Urology, Department of Uro-Gynaecological Oncology, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale,”, Naples, Italy
6Scientific Direction, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale,”, Naples, Italy
7Division of Radiation Oncology, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale,”, Naples, Italy
8Division of Medical Oncology–Centro di Riferimento Oncologico, Aviano, Italy
9Oncology Unit, A.O.R.N. dei COLLI “Ospedali Monaldi-Cotugno-CTO,”, Naples, Italy
Edited and reviewed by: Giovanni Li Volti, University of Catania, Italy
✉*Correspondence: Gaetano Facchini gafacchi@libero.it
This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology
Copyright © 2016 Cecere, Rossetti, Cavaliere, Della Pepa, Di Napoli, Crispo, Iovane, Piscitelli, Sorrentino, Ciliberto, Maiolino, Muto, Perdonà, Berretta, Pignata, Facchini and D'Aniello.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
